Lightbridge Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 10 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Cash and Cash Equivalents Balance Quarterly215.7MTarget: Sufficient to fund planned operations for the near term
Quarterly Net Loss Quarterly-6.3MTarget: Minimize cash burn during pre-revenue development phase
Quarterly Research and Development (R&D) Expenses Quarterly3.3MTarget: Disciplined allocation to fuel qualification and high-performance computing
Watch Items
- Irradiation Testing ProgressTrigger: Completion of key milestones at Idaho National Laboratory (INL)Action: Advance toward licensing submissions and commercialization agreements
- Equity Dilution from ATM OfferingsTrigger: Significant increase in outstanding shares (e.g., Q1 2026 ATM net proceeds of $18.6M)Action: Monitor share count expansion and impact on per-share valuation metrics
- Regulatory Approval and Licensing TimelinesTrigger: Feedback or delays from the U.S. Nuclear Regulatory Commission (NRC)Action: Adjust commercialization roadmap and preserve cash reserves accordingly
Research as of 19 Jun 2026